Page last updated: 2024-08-26

allocryptopine and Brugada Syndrome

allocryptopine has been researched along with Brugada Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, Y; Li, Y; Wei, G; Wen, Y; Xiang, G; Xing, Y; Xu, B; Yang, J; Zhang, J; Zhu, C	1

Other Studies

1 other study(ies) available for allocryptopine and Brugada Syndrome

Article	Year
Electrophysiological and trafficking defects of the SCN5A T353I mutation in Brugada syndrome are rescued by alpha-allocryptopine. European journal of pharmacology, 2015, Jan-05, Volume: 746 Topics: Amino Acid Substitution; Anti-Arrhythmia Agents; Berberine Alkaloids; Brugada Syndrome; Cell Membrane; Genes, Reporter; Green Fluorescent Proteins; HEK293 Cells; Humans; Kinetics; Membrane Potentials; Microscopy, Confocal; Mutagenesis, Site-Directed; Mutation; NAV1.5 Voltage-Gated Sodium Channel; Neuromuscular Agents; Patch-Clamp Techniques; Protein Transport; Recombinant Proteins; Voltage-Gated Sodium Channel Agonists	2015

Article

Year

Electrophysiological and trafficking defects of the SCN5A T353I mutation in Brugada syndrome are rescued by alpha-allocryptopine.

European journal of pharmacology, 2015, Jan-05, Volume: 746

Topics: Amino Acid Substitution; Anti-Arrhythmia Agents; Berberine Alkaloids; Brugada Syndrome; Cell Membrane; Genes, Reporter; Green Fluorescent Proteins; HEK293 Cells; Humans; Kinetics; Membrane Potentials; Microscopy, Confocal; Mutagenesis, Site-Directed; Mutation; NAV1.5 Voltage-Gated Sodium Channel; Neuromuscular Agents; Patch-Clamp Techniques; Protein Transport; Recombinant Proteins; Voltage-Gated Sodium Channel Agonists

2015